Alkermes says long-acting drugs could help schizophrenics stay on medication longer
Alkermes Plc said on Tuesday its long-acting injectable therapy for schizophrenia has helped reduce symptoms and can become an effective option for ensuring patients stay on medication even after being discharged from hospital.
from Reuters: Health News https://reut.rs/2uTOgF9
http://bit.ly/2zwRqiM